Last reviewed · How we verify

NCT04454814

Postoperative Pain After Root Canal Preparation Using Different Engine-driven Systems

Completed NA Last updated 2 July 2020
What this trial tests

NA trial testing Protaper Universal instruments in Asymptomatic Molar Teeth With Periapical Lesions in 120 participants. Completed in 15 February 2020.

Timeline
15 October 2017
Primary endpoint
15 January 2020
15 February 2020

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date15 October 2017
Primary completion15 January 2020
Estimated completion15 February 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 18 to 60, any sex, with Asymptomatic Molar Teeth With Periapical Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A hundred twenty patients who had an asymptomatic mandibular molar teeth with periapical lesion were included. For each patient, teeth were prepared with Reciproc Blue or Protaper Universal instruments. Each tooth was obturated with gutta-percha and resin-based sealer using single cone technique for mesial roots and for distal roots single cone and cold lateral compaction technique. Root canal treatment was performed in a single visit. Postoperative pain was assessed as no, mild, moderate, or severe at 6, 12, 24, 48, 72 hours and 7 days after obturation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04454814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing